Matthieu Schapira

Matthieu Schapira

SGC Toronto

Schapira

Matthieu Schapira

MaRS Centre, South Tower, 101 College St., Suite 700, Toronto, ON, M5G 1L7, Canada

Affiliations

Biography

Matthieu Schapira, PhD is a Professor in the Department of Pharmacology and Toxicology, UofT, and is the head of computational chemistry, protein bioinformatics, and data management at the SGC-Toronto. He leads the CACHE initiative for benchmarking computational ‘hit finding’. Dr. Schapira is a recognized authority in the structural chemistry of drug target classes such as chromatin regulators, ubiquitylation pathways and WDR proteins, and has created popular online informatics resources for these targets such as Chromohub, Ubihub and ChemBioPort. He is interested in novel strategies to expand and ML tools to exploit the accessible chemistry space. His trainees have gone on to become important innovators in AI-driven drug discovery at Toronto-born biotechs such as Atomwise and Cyclica.

Positions available

2015

A Potent, Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 3 (PRMT3).

Kaniskan HÜ, Szewczyk MM, Yu Z, Eram MS, Yang X, Schmidt K, Luo X, Dai M, He F, Zang I, Lin Y, Kennedy S, Li F, Dobrovetsky E, Dong A, Smil D, Min SJ, Landon M, Lin-Jones J, Huang XP, Roth BL, Schapira M, Atadja P, Barsyte-Lovejoy D, Arrowsmith CH, Brown PJ, Zhao K, Jin J, Vedadi M

Angew. Chem. Int. Ed. Engl.. 2015-2-27 . .doi: 10.1002/anie.201412154

PMID: 25728001

2014

Structural biology and chemistry of protein arginine methyltransferases.

Schapira M, Ferreira de Freitas R

Medchemcomm. 2014-12-19 . 5(12):1779-1788 .doi: 10.1039/c4md00269e

PMID: 26693001

BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.

Gu L, Frommel SC, Oakes CC, Simon R, Grupp K, Gerig CY, Bär D, Robinson MD, Baer C, Weiss M, Gu Z, Schapira M, Kuner R, Sültmann H, Provenzano M, Yaspo ML, Brors B, Korbel J, Schlomm T, Sauter G, Eils R, Plass C, Santoro R

Nat. Genet.. 2014-12-8 . .doi: 10.1038/ng.3165

PMID: 25485837

A global assessment of cancer genomic alterations in epigenetic mechanisms.

Shah MA, Denton EL, Arrowsmith CH, Lupien M, Schapira M

Epigenetics Chromatin. 2014-12-4 . 7(1):29 .doi: 10.1186/1756-8935-7-29

PMID: 25484917

(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells.

Barsyte-Lovejoy D, Li F, Oudhoff MJ, Tatlock JH, Dong A, Zeng H, Wu H, Freeman SA, Schapira M, Senisterra GA, Kuznetsova E, Marcellus R, Allali-Hassani A, Kennedy S, Lambert JP, Couzens AL, Aman A, Gingras AC, Al-Awar R, Fish PV, Gerstenberger BS, Roberts L, Benn CL, Grimley RL, Braam MJ, Rossi FM, Sudol M, Brown PJ, Bunnage ME, Owen DR, Zaph C, Vedadi M, Arrowsmith CH

Proc. Natl. Acad. Sci. U.S.A.. 2014-8-18 . .doi: 10.1073/pnas.1407358111

PMID: 25136132

Trimethylation of Histone H3 Lysine 36 by Human Methyltransferase PRDM9.

Eram MS, Bustos SP, Lima-Fernandes E, Siarheyeva A, Senisterra G, Hajian T, Chau I, Duan S, Wu H, Dombrovski L, Schapira M, Arrowsmith CH, Vedadi M

J. Biol. Chem.. 2014-3-14 . .doi: 10.1074/jbc.M113.523183

PMID: 24634223

A Basic Post-SET Extension of NSDs Is Essential for Nucleosome Binding In Vitro.

Allali-Hassani A, Kuznetsova E, Hajian T, Wu H, Dombrovski L, Li Y, Gräslund S, Arrowsmith CH, Schapira M, Vedadi M

J Biomol Screen. 2014-3-4 . .doi: 10.1177/1087057114525854

PMID: 24595546

2013

Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations.

Wu H, Zeng H, Dong A, Li F, He H, Senisterra G, Seitova A, Duan S, Brown PJ, Vedadi M, Arrowsmith CH, Schapira M

PLoS ONE. 2013-12-19 . 8(12):e83737 .doi: 10.1371/journal.pone.0083737

PMID: 24367611

ChromoHub V2: Cancer Genomics.

Shah MA, Denton EL, Liu L, Schapira M

Bioinformatics. 2013-12-6 . .doi: 10.1093/bioinformatics/btt710

PMID: 24319001

Crystal structures of the human histone H4K20 methyltransferases SUV420H1 and SUV420H2.

Wu H, Siarheyeva A, Zeng H, Lam R, Dong A, Wu XH, Li Y, Schapira M, Vedadi M, Min J

FEBS Lett.. 2013-11-29 . 587(23):3859-68 .doi: 10.1016/j.febslet.2013.10.020

PMID: 24396869